Molecular biology of human immunodeficiency virus type-1.
Tremendous progress has been made in our understanding of the multiplication and pathogenesis of the human immunodeficiency virus, the causative agent of acquired immunodeficiency syndrome (AIDS). To block virus multiplication several targets in the life cycle of the virus have already been identified for which antiviral drugs can be developed and gene therapy can be envisaged as a possible treatment or cure of AIDS. The combination of several therapies might be needed for effective treatment. Prevention of HIV infections through effective vaccines still awaits novel, unconventional strategies.
Joshi
S
S
Department of Medical Genetics and Microbiology, University of Toronto, Ontario, Canada.
Joshi
R L
RL
D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics / Q000821:virology*; D015967:Gene Expression Regulation, Viral; D005814:Genes, Viral; D015497:HIV-1 / Q000235:genetics*; D006801:Humans